<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Sample volume as a key design parameter in affinity-based biosensors - Health AI Hub</title>
    <meta name="description" content="This paper addresses the critical yet underexplored role of sample volume in affinity-based biosensor design, where performance hinges on the absolute number of">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Sample volume as a key design parameter in affinity-based biosensors</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2512.21997v1" target="_blank">2512.21997v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-12-26
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Daan Beijersbergen, J√©r√¥me Charmet
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> q-bio.QM
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.95 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2512.21997v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2512.21997v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper addresses the critical yet underexplored role of sample volume in affinity-based biosensor design, where performance hinges on the absolute number of target molecules, not just concentration. The authors developed a tractable two-compartment mathematical model that integrates mass transport, Langmuir kinetics, and mass conservation to accurately predict assay time and minimum required sample volume. This model, validated experimentally and computationally, drastically reduces design optimization time and provides quantitative rules to enhance biosensor sensitivity and performance, particularly for point-of-care applications.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>Optimizing biosensor design for limited sample volumes is paramount for accurate, rapid, and efficient diagnostics, particularly in point-of-care testing and resource-constrained environments, directly impacting timely patient care and effective health monitoring.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>Not explicitly an AI application in the sense of machine learning or deep learning for health outcomes. It describes a mathematical model and open-source software for computational optimization of biosensor design, which is a tool for engineering medical devices rather than a direct AI application for diagnosis or treatment.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Sample volume is identified as a critical but underexplored design parameter for affinity biosensors, especially when sample availability is limited.</li>
                    
                    <li>A tractable two-compartment mathematical model was developed, integrating simplified mass transport, Langmuir binding kinetics, and mass conservation under finite volume constraints.</li>
                    
                    <li>The model accurately predicts critical performance metrics, including assay time and minimum required sample volume, as validated against experimental measurements and numerical simulations.</li>
                    
                    <li>It achieves a more than 10,000-fold reduction in computational time compared to commercial simulation packages for biosensor design optimization.</li>
                    
                    <li>Quantitative design rules were derived for biosensor optimization that explicitly account for measurement time and sample volume as primary decision variables.</li>
                    
                    <li>The framework was experimentally validated by optimizing flow rate parameters for a quartz crystal microbalance (QCM) biosensor and was retrospectively applied to enhance the sensitivity of published biosensor designs.</li>
                    
                    <li>The model and framework are released as open-source software to facilitate mechanistic insights, device performance optimization, and informed design decisions for researchers.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The authors developed a two-compartment mathematical model incorporating simplified mass transport, Langmuir binding kinetics, and mass conservation principles under finite volume constraints. This model was rigorously validated against both experimental measurements (e.g., QCM biosensor data) and results from commercial numerical simulation packages. Through systematic analysis of this model, quantitative design rules were derived.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>['The developed two-compartment mathematical model accurately predicts key biosensor performance metrics such as assay time and minimum required sample volume.', 'The model significantly reduces computational time for biosensor design optimization by over 10,000-fold compared to existing commercial tools.', 'Quantitative design rules were established, enabling explicit optimization of biosensors based on critical parameters like measurement time and available sample volume.', 'The derived framework successfully enhanced sensitivity in both newly optimized QCM biosensor experiments and retrospectively applied published biosensor designs.']</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This research provides a powerful, computationally efficient framework for designing and optimizing affinity-based biosensors to be more sensitive and efficient, especially in scenarios with scarce sample material. This directly facilitates the development of improved point-of-care diagnostic devices, accelerates health monitoring, and enhances the feasibility of advanced diagnostics in resource-constrained settings, ultimately leading to faster and more reliable clinical decision-making.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state any limitations of the developed model or framework.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The abstract does not explicitly outline future research directions by the authors, but highlights that the released open-source model enables researchers to gain mechanistic insights, optimize device performance, and make informed design decisions tailored to specific healthcare contexts, including point-of-care testing and resource-constrained environments.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Diagnostics</span>
                    
                    <span class="tag">Point-of-care testing</span>
                    
                    <span class="tag">Health monitoring</span>
                    
                    <span class="tag">Clinical laboratory</span>
                    
                    <span class="tag">Global health</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">affinity biosensors</span>
                    
                    <span class="tag tag-keyword">sample volume</span>
                    
                    <span class="tag tag-keyword">mathematical model</span>
                    
                    <span class="tag tag-keyword">mass transport</span>
                    
                    <span class="tag tag-keyword">Langmuir kinetics</span>
                    
                    <span class="tag tag-keyword">biosensor optimization</span>
                    
                    <span class="tag tag-keyword">point-of-care testing</span>
                    
                    <span class="tag tag-keyword">quantitative design rules</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Affinity-based biosensors have become indispensable in modern diagnostics and health monitoring. While considerable research has focused on optimizing analyte transport and binding kinetics, a fundamental parameter - sample volume - remains largely underexplored in biosensor design. This is critical because biosensor performance depends on the absolute number of target molecules present, not solely their concentration, making volume a key consideration where sample availability is limited. To address this gap, we developed a tractable two-compartment mathematical model integrating simplified mass transport, Langmuir binding kinetics, and mass conservation under finite volume constraints. Validated against experimental measurements and numerical simulations, the model accurately predicts critical performance metrics including assay time and minimum required sample volume while achieving more than a 10,000-fold reduction in computational time compared to commercial simulation packages. Through systematic analysis, we derived quantitative design rules for biosensor optimization that explicitly account for measurement time and sample volume as primary decision variables. We validated this framework experimentally by optimizing flow rate parameters for a quartz crystal microbalance (QCM) biosensor and retrospectively applied it to enhance sensitivity of published biosensor designs. Released as open-source software, our model enables researchers to gain mechanistic insights, optimize device performance, and make informed design decisions tailored to specific healthcare contexts, including point-of-care testing and resource-constrained environments.</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>30 pages including Main Article (19 pages, 6 figures) and Supplementary Material (11 pages, 10 figures)</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>